|
GTF2E1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.99520433297585E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6556755966235E-12 |
| Normal-vs-Stage2 |
9.10089781314127E-11 |
| Normal-vs-Stage3 |
6.66133814775094E-16 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
2.662200E-01 |
| Stage1-vs-Stage3 |
7.704000E-02 |
| Stage1-vs-Stage4 |
2.48309999999474E-05 |
| Stage2-vs-Stage3 |
3.172200E-02 |
| Stage2-vs-Stage4 |
6.43139999999542E-05 |
| Stage3-vs-Stage4 |
2.846000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.88418203051333E-15 |
| Normal-vs-AfricanAmerican |
8.62939997237078E-09 |
| Normal-vs-Asian |
2.12507789143501E-12 |
| Caucasian-vs-AfricanAmerican |
8.271200E-01 |
| Caucasian-vs-Asian |
9.736000E-01 |
| AfricanAmerican-vs-Asian |
8.727400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63691282750733E-12 |
| Normal-vs-Female |
1.62991842245219E-12 |
| Male-vs-Female |
9.398600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.6621374255883E-15 |
| Normal-vs-Age(41-60Yrs) |
1.63080660087189E-12 |
| Normal-vs-Age(61-80Yrs) |
1.37667655053519E-14 |
| Normal-vs-Age(81-100Yrs) |
7.90110000000732E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.895000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.491200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.671000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.598400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.822400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.950000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.715300E-03 |
| Classical-VS-Follicular |
9.346400E-01 |
| Classical-VS-Other |
2.903400E-01 |
| Classical-VS-Normal |
1.78856929267113E-13 |
| Tall-VS-Follicular |
7.021100E-03 |
| Tall-VS-Other |
6.839400E-01 |
| Tall-VS-Normal |
5.55111512312578E-16 |
| Follicular-VS-Other |
3.682200E-01 |
| Follicular-VS-Normal |
9.08606523353228E-13 |
| Other-VS-Normal |
7.67160000000322E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67454938804212E-12 |
| Normal-vs-N1 |
5.55111512312578E-16 |
| N0-vs-N1 |
2.779700E-02 |
|
|
